QTMeds

ALFUZOSINE ARROW LP 10 mg

Clinical Description (Database Summary)

(Hérité de ALFUZOSINE CRISTERS PHARMA LP 10 mg) Weak Ikr channel blocker based on hERG inhibition

Scientific Sources / References

https://pmc.ncbi.nlm.nih.gov/articles/PMC2483321/#B25, https://doi.org/10.4103/0253-7613.178825, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-287_Uroxatral_Admindocs_P5.pdf